Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (28) GO Terms (4) Nucleotides (100) Proteins (39) Interactants (51) Wiki
XB-GENEPAGE-996919

Papers associated with kcnc1



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes., Li X, Zheng Y, Li S, Nair U, Sun C, Zhao C, Lu J, Zhang VW, Maljevic S, Petrou S, Lin J., Ann Transl Med. September 1, 2021; 9 (18): 1397.

Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations., Cameron JM, Maljevic S, Nair U, Aung YH, Cogné B, Bézieau S, Blair E, Isidor B, Zweier C, Reis A, Koenig MK, Maarup T, Sarco D, Afenjar A, Huq AHMM, Kukolich M, Billette de Villemeur T, Nava C, Héron B, Petrou S, Berkovic SF., Ann Clin Transl Neurol. July 1, 2019; 6 (7): 1263-1272.      

KCNC1-related disorders: new de novo variants expand the phenotypic spectrum., Park J, Koko M, Hedrich UBS, Hermann A, Cremer K, Haberlandt E, Grimmel M, Alhaddad B, Beck-Woedl S, Harrer M, Karall D, Kingelhoefer L, Tzschach A, Matthies LC, Strom TM, Ringelstein EB, Sturm M, Engels H, Wolff M, Lerche H, Haack TB., Ann Clin Transl Neurol. July 1, 2019; 6 (7): 1319-1326.    

Kv3.1/Kv3.2 channel positive modulators enable faster activating kinetics and increase firing frequency in fast-spiking GABAergic interneurons., Boddum K, Hougaard C, Xiao-Ying Lin J, von Schoubye NL, Jensen HS, Grunnet M, Jespersen T., Neuropharmacology. May 15, 2017; 118 102-112.

A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy., Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, Møller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE., Nat Genet. January 1, 2015; 47 (1): 39-46.      

Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector., Cheikh A, Benkhalifa R, Landoulsi Z, Chatti I, Ayeb ME., Arch Pharm Res. November 1, 2014; 37 (11): 1445-53.

Erratum to: Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector., Cheikh A, Benkhalifa R, Landoulsi Z, Chatti I, El Ayeb M., Arch Pharm Res. November 1, 2014; 37 (11): 1505.

Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels., Tao H, Chen JJ, Xiao YC, Wu YY, Su HB, Li D, Wang HY, Deng MC, Wang MC, Liu ZH, Liang SP., Biochemistry. October 22, 2013; 52 (42): 7439-48.

A novel mechanism for fine-tuning open-state stability in a voltage-gated potassium channel., Pless SA, Niciforovic AP, Galpin JD, Nunez JJ, Kurata HT, Ahern CA., Nat Commun. January 1, 2013; 4 1784.              

Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1., Aidery P, Kisselbach J, Schweizer PA, Becker R, Katus HA, Thomas D., Gene. December 10, 2012; 511 (1): 26-33.        

Intermediate state trapping of a voltage sensor., Lacroix JJ, Pless SA, Maragliano L, Campos FV, Galpin JD, Ahern CA, Roux B, Bezanilla F., J Gen Physiol. December 1, 2012; 140 (6): 635-52.                      

Dynamic coupling of voltage sensor and gate involved in closed-state inactivation of kv4.2 channels., Barghaan J, Bähring R., J Gen Physiol. February 1, 2009; 133 (2): 205-24.                    

An update on MyoD evolution in teleosts and a proposed consensus nomenclature to accommodate the tetraploidization of different vertebrate genomes., Macqueen DJ, Johnston IA., PLoS One. February 6, 2008; 3 (2): e1567.        

Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current., Lagrutta A, Wang J, Fermini B, Salata JJ., J Pharmacol Exp Ther. June 1, 2006; 317 (3): 1054-63.

Pharmacology and surface electrostatics of the K channel outer pore vestibule., Quinn CC, Begenisich T., J Membr Biol. January 1, 2006; 212 (1): 51-60.              

A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels., Herrera D, Mamarbachi A, Simoes M, Parent L, Sauvé R, Wang Z, Nattel S., Mol Pharmacol. August 1, 2005; 68 (2): 305-16.

U-type inactivation of Kv3.1 and Shaker potassium channels., Klemic KG, Kirsch GE, Jones SW., Biophys J. August 1, 2001; 81 (2): 814-26.

Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes., Hinck D, Wulff H, Koppenhöfer E., Gen Physiol Biophys. March 1, 2001; 20 (1): 83-95.

Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium., Yue L, Wang Z, Rindt H, Nattel S., J Physiol. September 15, 2000; 527 Pt 3 467-78.

Antisense suppression of potassium channel expression demonstrates its role in maturation of the action potential., Vincent A, Lautermilch NJ, Spitzer NC., J Neurosci. August 15, 2000; 20 (16): 6087-94.                    

Sustained upregulation in embryonic spinal neurons of a Kv3.1 potassium channel gene encoding a delayed rectifier current., Gurantz D, Lautermilch NJ, Watt SD, Spitzer NC., J Neurobiol. February 15, 2000; 42 (3): 347-56.  

Regulation of Shaker-type potassium channels by hypoxia. Oxygen-sensitive K+ channels in PC12 cells., Conforti L, Millhorn DE., Adv Exp Med Biol. January 1, 2000; 475 265-74.

Role of transmembrane segment S5 on gating of voltage-dependent K+ channels., Shieh CC, Klemic KG, Kirsch GE., J Gen Physiol. June 1, 1997; 109 (6): 767-78.                

A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity., Cotton J, Crest M, Bouet F, Alessandri N, Gola M, Forest E, Karlsson E, Castañeda O, Harvey AL, Vita C, Ménez A., Eur J Biochem. February 15, 1997; 244 (1): 192-202.

Hydrophobic mutations alter the movement of Mg2+ in the pore of voltage-gated potassium channels., Harris RE, Isacoff EY., Biophys J. July 1, 1996; 71 (1): 209-19.

Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels., Jarolimek W, Soman KV, Alam M, Brown AM., Mol Pharmacol. January 1, 1996; 49 (1): 165-71.

The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway., Aiyar J, Nguyen AN, Chandy KG, Grissmer S., Biophys J. December 1, 1994; 67 (6): 2261-4.

The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells., Grissmer S, Ghanshani S, Dethlefs B, McPherson JD, Wasmuth JJ, Gutman GA, Cahalan MD, Chandy KG., J Biol Chem. October 15, 1992; 267 (29): 20971-9.

???pagination.result.page??? 1